While probiotic supplements have been touted as a gut-health booster, recent research shows why three groups of people may ...

The first few months of 2025 brought hope to the rare disease community. Food and Drug Administration leadership promised ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

The recall is currently categorized as Class II by the FDA, meaning that use of the product “may cause temporary or medically ...

Feel Free, a drink with kratom and kava, is advertised as a wellness supplement, but many people say they are becoming ...

COVID is once again climbing to troubling levels in California — a worrying trend as health officials attempt to navigate a ...

Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug in ...

MassBio report shows venture capital investment declining to 2017 levels as industry leaders compare the situation to America ...

The Alliance for Natural Health, an advocacy group, believes the FDA has unfairly muzzled companies. It is asking the FDA to ...

I am a woman in my late 60s with a family history that includes an older brother who had a heart attack at a young age. My ...

Bryan Hubbard in 2023 wanted Kentucky to be the first state to study the psychedelic ibogaine to treat opioid addiction, but he was rejected. Texas just agreed, earmarking $50M for the study.

Doctors say hormone therapy is a great option for many, but not all, menopausal women — and it's important to understand the ...